ArticleMedicina (Kaunas, Lithuania)2022

The Use of High Initial Doses of Botulinum Toxin Therapy for Cervical Dystonia Is a Risk Factor for Neutralizing Antibody Formation-A Monocentric Cross-Sectional Pilot Study.

Harald Hefter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.